Profile data is unavailable for this security.
About the company
IDEXX Laboratories, Inc. develops, manufactures and distributes products and provides services primarily for the companion animal veterinary, livestock and poultry, dairy and water testing industries. The Company also provides human medical point-of-care and laboratory diagnostics. Its segments include Companion Animal Group (CAG), Water quality products (Water), and Livestock, Poultry and Dairy (LPD). The CAG segment offers diagnostic and information management-based products and services for the companion animal veterinary industry, including in-clinic diagnostic solutions, outside reference laboratory services, and veterinary software and services. The Water segment provides testing solutions for accurate detection and quantification of various microbiological parameters in water. The LPD segment provides diagnostic tests, services, and related instrumentation that are used to manage the health status of livestock and poultry, and to improve the quality and safety of milk.
- Revenue in USD (TTM)3.93bn
- Net income in USD894.97m
- Incorporated1983
- Employees11.00k
- LocationIDEXX Laboratories IncOne Idexx DriveWESTBROOK 04092-2041United StatesUSA
- Phone+1 (207) 556-0300
- Fax+1 (207) 556-4346
- Websitehttps://www.idexx.com/
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Steris PLC | 5.46bn | 610.12m | 22.43bn | 17.79k | 37.02 | 3.39 | 20.62 | 4.11 | 6.16 | 6.20 | 55.11 | 67.18 | 0.5148 | 4.87 | 5.32 | 306,938.50 | 5.77 | 5.04 | 6.36 | 5.51 | 44.01 | 43.75 | 11.20 | 10.69 | 1.39 | 12.76 | 0.236 | 37.51 | 6.24 | 12.49 | 10.64 | 8.40 | 11.52 | 8.99 |
| DexCom Inc | 4.15bn | 535.20m | 32.69bn | 10.30k | 63.93 | 14.42 | 42.99 | 7.88 | 1.30 | 1.30 | 10.11 | 5.78 | 0.6269 | 2.89 | 3.89 | 402,718.40 | 8.09 | 8.79 | 12.44 | 11.75 | 60.72 | 64.97 | 12.90 | 14.90 | 1.32 | -- | 0.5246 | 0.00 | 11.34 | 22.27 | 6.41 | 41.63 | 14.79 | -- |
| GE HealthCare Technologies Inc | 19.80bn | 2.18bn | 34.40bn | 53.00k | 15.80 | 3.74 | 12.20 | 1.74 | 4.76 | 4.76 | 43.13 | 20.07 | 0.6018 | 5.54 | 4.51 | 373,547.20 | 6.84 | -- | 9.67 | -- | 41.99 | 40.35 | 11.37 | 10.78 | 0.7601 | 8.18 | 0.483 | 1.19 | 0.6138 | 3.41 | 43.48 | 3.82 | 3.91 | -- |
| Agilent Technologies Inc | 6.63bn | 1.17bn | 35.02bn | 18.00k | 30.34 | 5.70 | 24.27 | 5.28 | 4.06 | 4.06 | 23.09 | 21.61 | 0.576 | 3.08 | 5.07 | 370,279.30 | 10.13 | 10.93 | 12.25 | 13.09 | 53.77 | 53.35 | 17.59 | 17.93 | 1.60 | 24.95 | 0.3629 | 21.83 | -4.73 | 4.75 | 3.95 | 3.77 | 19.36 | 7.80 |
| Resmed Inc | 5.02bn | 1.31bn | 37.30bn | 9.98k | 28.56 | 6.73 | 24.52 | 7.43 | 8.91 | 8.91 | 34.05 | 37.83 | 0.6983 | 2.45 | 5.65 | 503,159.20 | 18.26 | 14.24 | 20.73 | 16.53 | 58.76 | 56.85 | 26.15 | 20.35 | 2.49 | 58.86 | 0.1082 | 32.62 | 10.95 | 12.44 | 13.75 | 19.98 | 8.23 | 5.89 |
| IDEXX Laboratories Inc | 3.93bn | 894.97m | 42.89bn | 11.00k | 49.29 | 29.74 | 41.68 | 10.91 | 10.82 | 10.82 | 47.53 | 17.93 | 1.20 | 3.87 | 6.81 | 357,439.60 | 27.26 | 28.11 | 40.01 | 42.15 | 61.28 | 59.56 | 22.76 | 22.19 | 0.8111 | 53.37 | 0.3937 | 0.00 | 6.46 | 10.12 | 5.07 | 15.73 | -3.35 | -- |
| Veeva Systems Inc | 2.86bn | 780.66m | 45.08bn | 7.29k | 58.53 | 7.24 | 54.89 | 15.79 | 4.71 | 4.71 | 17.25 | 38.11 | 0.4093 | -- | 6.06 | 391,622.10 | 11.19 | 11.33 | 13.85 | 14.35 | 75.50 | 72.60 | 27.34 | 23.96 | -- | -- | 0.00 | 0.00 | 16.20 | 19.99 | 35.84 | 18.85 | 36.56 | -- |
| Edwards Lifesciences Corp | 5.54bn | 1.44bn | 45.78bn | 15.80k | 32.20 | 4.52 | 29.01 | 8.27 | 2.42 | 7.00 | 9.31 | 17.28 | 0.4867 | 0.984 | 7.45 | 350,557.00 | 12.63 | 14.52 | 14.28 | 16.61 | 79.38 | 79.01 | 25.95 | 25.54 | 3.66 | -- | 0.0554 | 0.00 | 8.57 | 4.58 | 14.55 | 5.94 | 0.2857 | -- |
| Becton Dickinson and Co | 20.87bn | 1.50bn | 50.43bn | 74.00k | 34.08 | 2.00 | 13.04 | 2.42 | 5.16 | 5.16 | 71.96 | 88.07 | 0.3842 | 3.32 | 7.47 | 281,986.50 | 2.76 | 2.55 | 3.20 | 2.92 | 44.68 | 45.30 | 7.18 | 7.29 | 0.6427 | 7.18 | 0.4329 | 76.93 | 4.16 | 3.14 | 15.99 | 10.56 | -5.40 | 4.29 |
| Cencora Inc | 310.23bn | 1.69bn | 57.22bn | 42.00k | 34.26 | 56.48 | 20.35 | 0.1844 | 8.62 | 8.62 | 1,574.00 | 5.23 | 4.59 | 16.40 | 12.70 | 7,386,481.00 | 2.53 | 1.12 | 10.78 | 4.84 | 3.29 | 3.24 | 0.55 | 0.2556 | 0.517 | 17.30 | 0.8694 | 62.15 | 12.12 | 10.36 | -13.53 | 13.02 | 9.45 | 4.98 |
| Holder | Shares | % Held |
|---|---|---|
| The Vanguard Group, Inc.as of 31 Mar 2025 | 9.47m | 11.64% |
| BlackRock Fund Advisorsas of 31 Mar 2025 | 5.44m | 6.69% |
| SSgA Funds Management, Inc.as of 31 Mar 2025 | 3.65m | 4.49% |
| Fundsmith LLPas of 31 Mar 2025 | 3.50m | 4.31% |
| Geode Capital Management LLCas of 31 Mar 2025 | 2.41m | 2.96% |
| BAMCO, Inc.as of 31 Mar 2025 | 2.06m | 2.53% |
| T. Rowe Price Associates, Inc. (IM)as of 31 Mar 2025 | 1.87m | 2.30% |
| William Blair Investment Management LLCas of 31 Mar 2025 | 1.73m | 2.13% |
| BlackRock Advisors (UK) Ltd.as of 31 Mar 2025 | 1.15m | 1.42% |
| Principal Global Investors LLCas of 31 Mar 2025 | 1.13m | 1.39% |
